Robert Kristal - Feb 13, 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: Chief Financial Officer
Signature: /s/ Robert Kristal
Stock symbol: BRTX
Transactions as of: Feb 13, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/15/2024, 04:17 PM
Previous filing: Feb 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BRTX	Common Stock						7.99K	Feb 13, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRTX	Stock Option	Award	$0	+263K		$0.00	263K	Feb 13, 2024	Common Stock	263K	$1.45	Direct	F3
holding	BRTX	Stock Option						10.5K	Feb 13, 2024	Common Stock	10.5K	$5.08	Direct	F1
holding	BRTX	Stock Option						89K	Feb 13, 2024	Common Stock	89K	$2.91	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is currently exercisable.
F2	The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
F3	The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested.